In the current study, we used a large sample of patients with MDD (n = 561) to replicate our previous findings of a predictive role of BDNF exon IV promoter hypomethylation (11) and early peripheral BDNF changes (7, 33) for remission of MDD. This evidence concerns the gene BDNF and major depressive disorder.